Warning on risks: Financial contracts for difference are complex instruments and are associated with a high risk of rapid financial losses due to leverage. On 81.54% of retail investor accounts, financial losses occur when trading financial contracts for difference with this provider. You should consider whether you understand how financial contracts for difference work, and whether you can afford to take the high risk of suffering financial losses. Please read the Risk Disclosures.

Market analysis and news

Get an overview of current market developments with regular analysis from our analysts. We offer a detailed view of key events, economic indicators and investment opportunities. Follow the development of the markets with us and make decisions based on data and experience.

Study

How We Went From Savers to Investors

35 Years Since the Beginning of Voucher Privatization in Czechoslovakia

JwMogvdam9p09SLN Shutterstock 1848610828 (1)

14/12/2022

Will Logistics Overcome Supply Chain Challenges?

Companies in the logistics and transport industries faced many challenges in the past few years and have drastically changed the way they operate. Driver shortages, capacity issues, shipping delays and piercing global inflation are among the hurdles which led to increased freight and labor costs. The industry had to overcome much hardship during the infamous COVID-19 pandemic, along with recent economic & political escalations the world has succumbed to.

28/11/2022

Is It the Right Time to Invest in Stocks?

In the past 100 years, the world has witnessed close to 15 years of recessions & downturns, characterized by wounding inflationary pressures, underwhelming business performance and pale investor sentiment which deteriorated economies.

QpeArDIwY9OroByE Shutterstock 1695624856

20/10/2022

Moderna vs. Pfizer – Who’s Winning?

After COVID-19 infected the globe, a slew of companies raced to create the ultimate vaccine which would promise extraordinary returns. Those which successfully tackled the epidemic via vaccines & pills were Pfizer, Moderna, Johnson & Johnson, Sputnik, among others.

17/8/2022

Development of major vaccine suppliers - Pfizer, BioNTech, Moderna

For the pharmaceutical companies that developed the Covid-19 vaccine, the approval of the fourth dose of the vaccine has been important over the past year. The US FDA approved it during March 2022, allowing companies to begin sales a few months ago. Let's take a look at whether the sale of the last dose had a direct impact on the development of the companies' shares and how the pharmaceutical leaders are doing today.

Latest analyses